z-logo
open-access-imgOpen Access
S746 Infliximab Monotherapy Has Lower Rates of Treatment Discontinuation and Healthcare Utilization When Compared to Combination Therapy
Author(s) -
Alexander Beschloss,
Erik X. Tan,
Vivek Nimgaonkar,
Daniel Travis,
Nathaniel Fessehaie,
Gary R. Lichtenstein,
Mark T. Osterman,
Abhik Bhattacharya
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776516.70107.b6
Subject(s) - medicine , infliximab , discontinuation , azathioprine , retrospective cohort study , combination therapy , gastroenterology , surgery , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here